Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
acetylon pharmaceuticals
ambys medicines
biotech
boston blog main
boston top stories
cell therapy
constellation pharmaceuticals
deals
gene therapy
genentech
holger willenbring
1
×
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
national blog main
1
×
national top stories
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
1
×
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
startups
takeda
third rock ventures
ucsf
university of illinois urbana-champaign
vc
warp drive bio
What
aiming
ambys
big
biotech
control
deadly
1
×
deal
debuted
diseases
formed
future
launch
liver
make
medicines
new
startup
takeda
today
treatments
1
×
unusual
variety
Language
Current search:
deadly
×
treatments
×
" national blog main "
×
" holger willenbring "
×
" salk institute for biological studies "
×
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?